Skip to main navigation Skip to search Skip to main content

Treatment with human chorion-gonadotropin (pregnyl) of patients with vaginal bleeding in the first trimester of pregnancy

  • A. Dukovski*
  • *Corresponding author for this work
  • University Hospital Alexandrovska

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The author present a few years opinion for treatment of patients with vaginal bleeding in first trimester of pregnancy and obstetrical complications with Pregnyl(Organon). The basics factors for inclusion in examination group are pregnant women in early pregnancy complicated with vaginal bleeding, with or not a pain. Overall 34 patients whose be treatment, 31 delivered lived and health child, one patient delivered baby with osteogenesis imperfecta and 2 patients the pregnancy is bracked with spontaneous abortion. The treatment with Pregnyl is very good method in patients with infertilitas, polycystosis ovarii and vaginal bleeding in early pregnancy. The doses of Pregnyl is 10,000 E i.m. (bolus dose), 5,000 E i.m. two times weekly between the first dose and 10 weeks of pregnancy, 5,000 E i.m. weekly between 10 and 14 weeks of pregnancy.
Original languageEnglish
Pages (from-to)13-17
JournalAkusherstvo i ginekologiia
Volume41
Issue number4
Publication statusPublished - 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Treatment with human chorion-gonadotropin (pregnyl) of patients with vaginal bleeding in the first trimester of pregnancy'. Together they form a unique fingerprint.

Cite this